Research libraryMOLEKUL / SOURCE RECORD

Three-year Russian comparison of Rumalon in workers with knee osteoarthritis

L. I. Alekseeva, A. N. Karyakin, A. V. Smirnov, L. I. Benevolenskaya · 1997 · Terapevticheskii Arkhiv, issue 5, pp. 64–66

Indexed 2026-11-12.

Human comparative studyFull text availableSource linked

Reported findings and study design

Reported findings

Open prospective comparison. Rumalon was given as 2 mL intramuscularly twice weekly for 15 injections per course, two courses per year for three years. Both groups could receive ibuprofen and physiotherapy. Ten treated participants and five controls withdrew.

Dose, route and schedule

Open prospective comparison. Rumalon was given as 2 mL intramuscularly twice weekly for 15 injections per course, two courses per year for three years. Both groups could receive ibuprofen and physiotherapy. Ten treated participants and five controls withdrew.

Protocol source ↗ · Original Russian article, pp. 64–66

Results · Original Russian article, pp. 64–66
MeasureResultComparison, timing and statistics
Pain with walkingAt the start of year two, the paper reports 0.69 versus 1.41 points with Rumalon and control (p<0.01).
Joint functionThe Lequesne index differed at 18 months (p<0.05). Knee range of motion favored the treated group (p<0.04).
Radiographic progressionThe authors found no statistically significant group difference.
Allergic reactionOne participant discontinued Rumalon during the third course after an allergic reaction.

Open treatment, unequal group sizes, withdrawals and concurrent care limit the symptom comparison.

Source for these results ↗ · Reviewed 2026-11-12

For research and education. Consult a qualified clinician for medical advice.

Study limitations and source details

Study limitations

  • Open treatment, unequal group sizes, withdrawals and concurrent care limit the symptom comparison.

Source access

Original Russian article, pp. 64–66

Source reviewed 2026-11-12.

Open source ↗

Citation and original source

Original source: L. I. Alekseeva, A. N. Karyakin, A. V. Smirnov, L. I. Benevolenskaya. Three-year Russian comparison of Rumalon in workers with knee osteoarthritis Terapevticheskii Arkhiv, issue 5, pp. 64–66 1997.

Molekul research summary: https://molekul.io/research/rumalon-alekseeva-1997. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards